The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells
Abstract
Mutations of the breast cancer susceptibility gene BRCA1 confer increased risk for breast, ovarian, and prostatic cancers, but it is not clear why the mutations are associated with these particular tumor types. In transient transfection assays, BRCA1 was found to inhibit signaling by the ligand-activated estrogen receptor (ER-α) through the estrogen-responsive enhancer element and to block the transcriptional activation function AF-2 of ER-α. These results raise the possibility that wild-type BRCA1 suppresses estrogen-dependent transcriptional pathways related to mammary epithelial cell proliferation and that loss of this ability contributes to tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
RetractedA Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse
Hakem, R., de la Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81302-1 · Cited by 667
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl
Somasundaram, K., Zhang, H., Zeng, Y.-X., Houvras, Y., Peng, Y., Zhang, H., Wu, G. S., Licht, J. D., Weber, B. L., & El-Deiry, W. S. (1997) · Nature · doi:10.1038/38291 · Cited by 509
Evidence for a transcriptional activation function of BRCA1 C-terminal region
Monteiro, A. N. A., August, A., & Hanafusa, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13595 · Cited by 446
Transcriptional activation by BRCA1
Chapman, M. S., & Verma, I. M. (1996) · Nature · doi:10.1038/382678a0 · Cited by 436
Estrogen Receptors: Bioactivities and Interactions with Cell Signaling Pathways1
Katzenellenbogen, B. S. (1996) · Biology of Reproduction · doi:10.1095/biolreprod54.2.287 · Cited by 374
Growth retardation and tumour inhibition by BRCA1
Holt, J. T., Thompson, M. E., Szabo, C., Robinson-Benion, C., Arteaga, C. L., King, M.-C., & Jensen, R. A. (1996) · Nature Genetics · doi:10.1038/ng0396-298 · Cited by 361
Flemington, E. K., Speck, S. H., & Kaelin, W. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6914 · Cited by 346
Rajan, J. V., Wang, M., Marquis, S. T., & Chodosh, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13078 · Cited by 219
Henttu, P. M. A., Kalkhoven, E., & Parker, M. G. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.1832 · Cited by 213
Watanabe, G., Albanese, C., Lee, R. J., Reutens, A., Vairo, G., Henglein, B., & Pestell, R. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3212 · Cited by 164
Self-citationRajan, J. V., Marquis, S. T., Gardner, H. P., & Chodosh, L. A. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8526 · Cited by 159
Nuclear Receptors in Sicily: All in the Famiglia
Perlmann, T., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80498-5 · Cited by 148
Induction of apoptosis by the tumor suppressor protein BRCA1.
Shao, N., Chai, Y. L., Shyam, E., Reddy, P., & Rao, V. N. (1996) · PubMed · Cited by 137
v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor
Baichwal, V. R., Park, A., & Tjian, R. (1991) · Nature · doi:10.1038/352165a0 · Cited by 78
Cited by
Nilsson, S., Mäkelä, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., & Gustafsson, J.-Å. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1535 · Cited by 1,996
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Roy, R., Chun, J., & Powell, S. N. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3181 · Cited by 1,469
Basal-Like Breast Cancer: A Critical Review
Rakha, E. A., Reis-Filho, J. S., & Ellis, I. O. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1748 · Cited by 1,164
Metadata
- Authors
- Fan, S., Wang, J.-A., Yuan, R., Ma, Y., Meng, Q., Erdos, M. R., Pestell, R. G., Yuan, F., Auborn, K. J., Goldberg, I. D., & Rosen, E. M.
- Venue
- Science
- Published
- 1999-05-21
- Volume
- 284
- Issue
- 5418
- Pages
- 1354-1356
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101791074
- Cited by
- 491
- References
- 18
- FWCI
- 18.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.